K+S Aktiengesellschaft, (KPLUY) Fair Value & Analysis
Basic Materials · US · Market cap $2.8B
Analysis
K+S Aktiengesellschaft, (KPLUY) currently trades at $7.71, while our model-based Fair Value estimate is $10.38 — implying the stock looks roughly 34.6% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, pharma, consumer, and community sectors in Europe, Germany, North America, South America, Asia, Africa, and Oceania. The company offers potassium chloride for crops, such as grain, corn, rice, soybeans, and sugar cane; fertilizer specialties that are used for crops with magnesium and sulfur requirements, including rapeseed, sugar beet, and potatoes, as well as for chloride-sensitive specialty crops such as citrus, grapes, coffee, almond trees, and vegetables; and water-soluble fertilizers for use in fertigation of fruit and vegetables under the KALISOP, KORN-KALI, ROLLKALI, PATENTKALI, ESTA KIESERIT, GRANUAID, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUCMS, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP brands. It also provides soil, fertigation, foliar fertilizers, natural rock salt, high-purity vaccum salt and mineral salt mixture…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.